Prelude Capital Management’s VistaGen Therapeutics VTGN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-20,200	Closed	-$106K	–	1255
2023 Q3	$106K	Buy	+20,200	New	+$106K	0.01%	846
2021 Q1	–	Sell	-5,012	Closed	-$292K	–	1412
2020 Q4	$292K	Buy	+5,012	New	+$292K	0.01%	523